Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014

4 references·7 citing·39 second hop

FromToDepth

this work references cited by second hop

References

2013Washington State Cancer Patients Found To Be At Greater Risk For Bankruptcy Than People Without A Cancer Diagnosis698 cited
2013Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia500 cited
2009Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs391 cited
2015Five Years of Cancer Drug Approvals301 cited

Cited by

2018Medical Financial Hardship among Cancer Survivors in the United States: What Do We Know? What Do We Need to Know?89 cited
2019The social and economic toll of cancer survivorship: a complex web of financial sacrifice78 cited
2018Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act77 cited
2018Bringing down the cost of cancer treatment72 cited
2018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues64 cited
2022Comparison of Cancer-Related Spending and Mortality Rates in the US vs 21 High-Income Countries62 cited
2021Financial worry and psychological distress among cancer survivors in the United States, 2013—201858 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work